AIMIRA Innovation Technology

AIMIRA Innovation Technology (also known as MIRA) is an AI-based medical technology company founded in 2021 and headquartered in Guangzhou, China. It develops an AI platform for medical aesthetics and anti-aging, improving diagnosis and treatment experience in plastic surgery and anti-aging medicine through artificial intelligence and deep learning. The company offers AI-powered diagnostic tools that enhance assessment accuracy and algorithms that optimize treatment plans based on patient-specific data. Its product portfolio includes the FDA-cleared Superflow Prime Treatment System, a plasma-based electrosurgical device with an integrated multi-spectral imaging (MSI) camera for pre- and post-treatment skin condition documentation.